drugset / Trial / NCT00145600
Therapy for Pediatric Hodgkin Lymphoma
Non-randomizedSingle-groupOpen-labelTreatment
Summary
With the success of current chemotherapy for Hodgkin's disease, the goal of this protocol is to maintain the currently successful cure rate and reduce treatment related side effects and long term toxicity. The main purpose of this study is to estimate the event free survival of patients treated with risk-adapted therapy compared to historical controls.
Timeline
- Start
- 2000-03-02
- Primary completion
- 2012-05-31
- Completion
- 2021-11-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Doxorubicin | Other / unclassified | — | — |
| Subject | Methotrexate | Small molecule | — | — |
| Subject | Prednisone | Other / unclassified | — | — |
| Subject | Vinblastine | Small molecule | — | — |